HEM Pharma Inc. (KOSDAQ:376270)

Market Cap	633.63B +397.3%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	7.17M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60,212
Average Volume	69,981
Open	91,000
Previous Close	94,000
Day's Range	83,800 - 94,100
52-Week Range	16,500 - 97,500
Beta	n/a
RSI	69.89
Earnings Date	Feb 13, 2026

About HEM Pharma

HEM Pharma Inc. operates as a microbiome healthcare company in South Korea and internationally. The company offers health functional food products, such as Nutrilite and my LAB microbiome solution. It also engages in the personalized analysis service and CDMO businesses. The company was founded in 2016 and is based in Pohang, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 376270